Cadila Healthcare informs about press release

18 Jul 2018 Evaluate

Cadila Healthcare has informed about press release titled, ' Zydus receives four consecutive ANDA approvals from the USFDA'.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

896.55 3.10 (0.35%)
28-Jan-2026 15:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1608.80
Dr. Reddys Lab 1221.00
Cipla 1329.20
Zydus Lifesciences 896.55
Lupin 2125.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×